Skip to Content

Aphria Inc. (APHA)

Securities Class Action

Overview
  • Date:
  • 12/6/2018
  • Company Name:
  • Aphria Inc.
  • Stock Symbol:
  • APHA
  • Class Period:
  • FROM 7/17/2018 TO 12/4/2018
  • Status:
  • Closed/Complete
  • Court:
  • U.S. District Court: Southern District of New York

Case Finder

Locate any case using the tools below.

NEW YORK, December 6, 2018 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Aphria Inc. (NYSE: APHA) securities between July 17, 2018 and December 4, 2018 the (“Class Period”).  Investors have until February 4, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint alleges that throughout the class period defendants made materially false and misleading statements and failed to disclose to investors: (i) that Latin American assets acquired by the company lacked adequate licenses to operate and were overvalued; and (ii) that the acquisition of Latin American assets would enrich the company’s CEO and other insiders at the expense of shareholders.  The complaint further alleges that, as a result of the foregoing, investors purchased Aphria’s securities at artificially inflated prices during the Class Period and suffered investment losses as a result of defendants’ conduct.

If you purchased Aphria securities on a US stock exchange, whether the NYSE or over the counter, during the Class Period or continue to hold shares purchased before the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below.  There is no cost or obligation to you.

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: